Wu Yi-Long and Tsuboi Masahiro and He Jie and John Thomas and Grohe Christian and Majem Margarita and Goldman Jonathan W. and Laktionov Konstantin and Kim Sang-We and Kato Terufumi and Vu Huu-Vinh and Lu Shun and Lee Kye-Young and Akewanlop Charuwan and Yu Chong-Jen and de Marinis Filippo and Bonanno Laura and Domine Manuel and Shepherd Frances A. and Zeng Lingmin and Hodge Rachel and Atasoy Ajlan and Rukazenkov Yuri and Herbst Roy S. and Kollaborációs szervezet: ADAURA Investigators and Somfay Attila and et al.:
Osimertinib in Resected EGFR-Mutated Non–Small-Cell Lung Cancer.
NEW ENGLAND JOURNAL OF MEDICINE, 383 (18).
pp. 1711-1723.
ISSN 0028-4793
(2020)
Soria Jean-Charles and Felip Enriqueta and Cobo Manuel and Lu Shun and Syrigos Konstantinos and Lee Ki Hyeong and Goeker Erdem and Georgoulias Vassilis and Li Wei and Isla Dolores and Guclu Salih Z and Morabito Alessandro and Min Young J and Ardizzoni Andrea and Gadgeel Shirish M and Wang Bushi and Chand Vikram K and Goss Glenwood D and Kollaborációs szervezet: LUX-Lung 8 Investigators and Somfay Attila and et al.:
Afatinib versus erlotinib as second-line treatment of patients with advanced squamous cell carcinoma of the lung (LUX-Lung 8): an open-label randomised controlled phase 3 trial.
LANCET ONCOLOGY, 16 (8).
pp. 897-907.
ISSN 1470-2045
(2015)